Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Uncovering the potential of APOD as a biomarker in gastric cancer: A retrospective and multi-center study

23 Feb 2024

Abstract excerpt

Gastric cancer (GC) poses a significant health challenge worldwide, necessitating the identification of predictive biomarkers to improve prognosis. Dysregulated lipid metabolism is a well-recognized hallmark of tumorigenesis, prompting investigation into apolipoproteins (APOs). In this study, we focused on apolipoprotein D (APOD) following comprehensive analyses of APOs in pan-cancer. Utilizing data from the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Ferroptosis and cancer prognosis
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38455068
DOI: 10.1016/j.csbj.2024.02.015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Uncovering the potential of APOD as a biomarker in gastric cancer: A retrospective and multi-center studyPMID 38455068Read ↗

Prognostic significance and immune characteristics of APOE in gastric cancerSemantic proximity Read ↗

Gastric cancer occurrence and heterogeneity: integration of clinical data, multi-omics and tumor microenvironment.Semantic proximity Read ↗

Identification of a Lipid Homeostasis Related Genes Signature in Predicting the Prognosis, Immunity, and Chemotherapeutic Effect for Patients With Gastric CancerSemantic proximity Read ↗

Gastric Cancer in the Era of Precision MedicineSemantic proximity Read ↗

Apolipoprotein C-II induces EMT to Promote Gastric Cancer Peritoneal Metastasis via PI3K/AKT/mTOR PathwaySemantic proximity Read ↗

An OLFM4‐Specific Tumor Subtype of Gastric Adenocarcinoma Exhibits Enhanced Palmitoylation and Energetic MetabolismSemantic proximity Read ↗

Fatty acid metabolism is related to the immune microenvironment changes of gastric cancer and RGS2 is a new tumor biomarkerSemantic proximity Read ↗

Genetics/genomics/proteomics of gastric adenocarcinoma.Semantic proximity Read ↗

Multi-omics analysis identifies diagnostic circulating biomarkers and potential therapeutic targets, revealing IQGAP1 as an oncogene in gastric cancerSemantic proximity Read ↗

The metabolic subtypes of gastric cancer reveal treatment preferencesSemantic proximity Read ↗

The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally.Semantic proximity Read ↗

The metabolic subtypes of gastric cancer reveal treatment preferencesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.